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ABSTRACTS 
 
Objective: To compare the combined effect of two traditional antiemetic drugs (metoclopramide and 
glycopyrrolate) against published data of effect of single antiemetic drug for prevention of nausea 
and vomiting in women undergoing lower section caesarean section under spinal anaesthesia 
Methods: Seventy eight full term parturient women undergoing lower segment cesarean section 
under spinal anaesthesia(using 5% lignocaine) were injected metoclopramide 10mg & glycopyrrolate 
0.2mg intravenously at the time of abdominal incision. The frequency of nausea and vomiting and 
Apgar scores of neonates were noted. Results: Incidence of nausea was noted in 3.84% during 
operative and post operative period. No incidence of vomiting and any other adverse effects were 
observed. Apgar scores were >8 in all neonates at one and five minutes. Conclusion: Incidence of 
vomiting is low (zero case) in current study group compared to groups(data from published research) 
with either metoclopramide or glycopyrrolate or ondansetron but observed differences are 
statistically insignificant, however the upper class interval limit of Z value falling above significance 
level (>1.96) in all groups suggesting that it might significant and required further studies to prove or 
disprove significantly lower incidences of nausea and vomiting if combine use of two drugs 
(glycopyrrolate plus metoclopramide) as a prophylactic antiemetic in elective cesarean section under 
spinal anesthesia. 
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INTRODUCTION 
The incidences of emetic symptoms are high 
during the pregnancy because of increased 
concentration of progesterone in the system. 
Progesterone decreases gastrointestinal motility 
and reduces lower oesophageal pressure. These 
physiological and anatomical changes may 
predispose the pregnant women to develop 
emetic tendency. 
Intra-operative emetic symptoms during 
abdominal surgery under regional anesthesia 
have a multi-factorial origin and factors such as 
psychological changes (anxiety), arterial 
hypotension, hypo-perfusion of the central 
nervous system, abrupt visceral movements, 
and concomitant opiate administration1 may 
have an influence on them. Additionally, there is 
a higher predisposition to intra operative nausea 
vomiting among patients at the end of their 
pregnancies, as a consequence of increased 
intra-abdominal pressure. 
The reported incidence of nausea and vomiting 
during cesarean section performed under 
regional anaesthesia varies from 50% to 80% 
when no prophylactic antiemetic is given.2-8 
A number of treatments have been introduced 
in order to reduce post operative nausea and 
vomiting (PONV), such as 5-HT3 antagonists  
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(ondansetron and granisetron), dopamine 
receptor antagonists, and antihistamine drugs. 
However, each of these treatments is associated 
with critical limiting factors, namely cost with 5-
HT3 antagonists, extrapyramidal symptoms 
with dopamine receptor antagonists, excessive 
sedation and tachycardia with antihistamine 
drugs.9-11 
Almost all previous researches on PONV 
prevention were using single prophylactic 
antiemetic drug. The purpose of present study 
was to compare the combined effect of  two 
traditional antiemetic drug i.e. metoclopramide 
and glycopyrrolate against published research 
data of  single antiemetic drug for prevention of 
nausea and vomiting in women undergoing 
cesarean section under spinal anaesthesia. 
 
MATERIALS AND METHODS 
Seventy eight full term parturient women of 
ASA I & II (American Society of Anesthesiology 
Grade I & II), aged between 19 and 35 years 
scheduled for elective lower segment cesarean 
section under spinal anaesthesia were subjects of 
the study. Patients with preeclampsia, arterial 
hypertension, chronic utero-placental 
insufficiency, history of acid peptic disease or 
fasting for less than 6 hours were excluded. The 
study period was between January 2010 and 
December 2010. 
Each patient received 20 ml per kilogram of 
lactated Ringer’s solution before administration 
of spinal anaesthesia to prevent hypotension. All 
patients received oxygen via a face mask at a 
flow rate of 3 liters per minutes since induction 
of spinal anaesthesia. Patients were positioned 
in the right/left lateral decubitus or sitting 
position and a 22 gauge spinal needle was 
introduced through mid line approach at the 
L3–L4 inter-space. Patients received 2 ml of 5% 
lignocaine (hyperbaric) subarachnoid injection 
and turned in supine position with left uterine 
displacement to avoid aorto-caval compression. 
Surgery was started when a sensory block up to 
T5 dermatome was obtained.  Each patient 
received 10 mg of metoclopramide and 0.2 mg of 
glycopyrrolate intravenously when surgery 
started. 
Hypotension was defined as a reduction of more 
than 20% from baseline pressure or if systolic 
blood pressure was less than 90 mmHg and 
managed with bolus intravenous  lactated 
Ringer’s solution and ephedrine in 10-mg 
increments. 
Each patient was observed and asked for the 
intra-operative occurrence of nausea and 
vomiting. Apgar scores were obtained at 1 and 5 
minutes. Each patient remained in the recovery 
room for 4 hours and was observed by the 
nursing staff for the postoperative occurrence of 
nausea and vomiting. 
Results are analyzed manually by suitable 
statistical tests. 
 
OBSERVATIONS AND RESULTS 
Incidence of nausea was noted in 3(3.84%) of 
total 78 studied subjects during operative/post-
operative period. No incidence of vomiting was 
observed. Noticeable side effects of 
metoclopramide and glycopyrrolate were not 
found in any studied subjects. Apgar scores 
were >8 in all neonates at one and five minutes. 
 
Table 1: Published researches showing effect of antiemetic drugs during operative and post operative 
period of cesarean section under spinal anaesthesia in American Society of Anesthesiology grade I & 
II full term parturient women 
Antiemetic drugs Æ Metoclopramide  (10mg)  Ondansetron(4mg) 
Observation Biswas  et 
al12  
(n=20) 
Ali Shahriari 
at al13  
(n=40) 
Garcia-Migual 
FJ at al14 
(n=48) 
A K Pan 
at al8 
(n=20) 
Garcia-Migual 
FJ at al14 
(n=49) 
Nausea (%)  4(20)  21(52.5)  3(6.25)  2(10)  4(8.16) 
Vomiting (%)  2(10)  0  1(2.08)  1(5)  0 
 
DISCUSSION 
Great care had been taken to design 
methodology such a way that made possible to 
compare findings with previous researches.  
Present study found no side effects of 
combination of metoclopramide (10mg) and 
glycopyrrolate (0.2mg) on parturient women 
and neonates. The Apgar scores were acceptable  
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range of 8-10 at one and five minutes suggesting 
safety of drugs. Similar drug safety of 
Metoclopramide was observed by Lussos SA at 
al3, Biswas et al12  and Ali Shahriari at al 13. 
Similarly, Biswas et al12 and Ure D at al15 found 
that Glycopyrrolate was safe to neonates and no 
adverse effects found in patients. 
Study results were compared with 
Glycopyrrolate alone shows lower in incidence 
of nausea and vomiting but statistically 
insignificant at 95% significance level (Table 2). 
 
Table 2: Comparison of antiemetic effect of metoclopramide plus glycopyrrolate to glycopyrrolate 
alone during operative and post operative period of cesarean section under spinal anaesthesia in 
American Society of Anesthesiology grade I & II full term parturient women 
Observation Metoclopramide(10mg)  + 
Glycopyrrolate(0.2mg) 
% (n=78) 
Glycopyrrolate 
(0.2mg)12 
% (n=20) 
Z value 
(Class Interval) 
at 95% CL 
P value 
(95% C.L.) 
Nausea  3.84  10  0.87 (-1.08, 2.83)  0.38 
Vomiting  0  5  1.02 (-0.93, 2.98)  0.30 
 
Table 3: Comparison of antiemetic effect of metoclopramide plus glycopyrrolate to metoclopramide 
alone during operative and post operative period of cesarean section under spinal anaesthesia in 
American Society of Anesthesiology grade I & II full term parturient women  
Observation Metoclopramide(10mg)  + 
Glycopyrrolate(0.2mg) 
% (n=78) 
Metoclopramide 
(10mg) 
% (n=108)* 
Z value 
(Class Interval) 
at 95% CL 
P value 
(95% C.L.) 
Nausea 3.84  25.92  4.65  (2.67,  6.61)  <0.001 
Vomiting   0  2.77  1.75 (-0.020, 3.70)  0.08 
*combine data, incorporated from studies by Biswas et al12, Ali Shahriari 13 & Garcia-Migual FJ at al14  
 
Study results were compared with 
Metoclopramide alone shows lower in incidence 
of nausea and vomiting but the incidence of 
vomiting is statistically insignificant at 95% 
confidence limits (Table 3). 
 
Table 4: C o m p a r i s o n  o f  a n t i e m e t i c  e f f e c t  o f  m e t o c l opramide plus glycopyrrolate to ondansetron 
during operative and post operative period of cesarean section under spinal anaesthesia in American 
Society of Anesthesiology grade I & II full term parturient women  
Observation Metoclopramide(10mg)  + 
Glycopyrrolate(0.2mg) 
% (n=78) 
Ondansetron(4mg) 
% (n=69)# 
 
Z value 
(Class Interval) 
at 95% CL 
P value 
(95% C.L.) 
Nausea  3.84  8.69  1.20 (-0.75, 3.16)  0.22 
Vomiting   0  1.44  1.00 (-0.95, 2.96)  0.31 
# combined data, incorporated from studies by A K Pan at al8 & Garcia-Migual FJ at al14  
 
Study results were compared with ondansetron 
shows lower in incidence of nausea and 
vomiting in current study group but statistically 
insignificant at 95% confidence limits (Table 4). 
Although, incidence of nausea was low and 
statistically significant (p <0.001) when study 
group compared to group with metoclopramide 
alone drug (Table 3) have comparatively 
moderate value as nausea is discomfort, not 
complication. Again, nausea is a subjective 
sensation which interfering in valid 
comparisons.  
 
CONCLUSION AND RECOMMENDATION: 
Incidence of vomiting is low (zero case) in 
current study group compared to groups with 
either metoclopramide or glycopyrrolate or 
ondansetron. However, observed differences are 
statistically insignificant, the upper class interval 
limit of Z value falling at significant level (>1.96)  
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in all groups. It suggest, observed lower 
incidence of nausea and vomiting in current 
study group (glycopyrrolate + metoclopramide) 
may be significant in future studies or if sample 
s i z e  i n c r e a s e d .  S o  w e  r e c o m m e n d e d  f u r t h e r  
studies to prove or disprove our findings of 
lower incidences of nausea and vomiting if 
combine two drugs (glycopyrrolate plus 
metoclopramide) as a prophylactic antiemetic in 
elective cesarean section under spinal 
anesthesia.  
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